These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12938827)

  • 1. Influence of simvastatin on aspects of thrombogenesis in CAPD patients.
    Malyszko J; Malyszko JS; Hryszko T; Mysliwiec M
    Perit Dial Int; 2003; 23(3):260-6. PubMed ID: 12938827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Simvastatin and extrinsic coagulation pathway in peritoneally dialyzed patients].
    Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Myśliwiec M
    Pol Arch Med Wewn; 2002 Jun; 107(6):519-24. PubMed ID: 12371384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive study on hemostasis in CAPD patients treated with erythropoietin.
    Malyszko J; Suchowierska E; Malyszko JS; Mysliwiec M
    Perit Dial Int; 2002; 22(5):582-92. PubMed ID: 12455569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term treatment with simvastatin on some hemostatic parameters in continuous ambulatory peritoneal dialysis patients.
    Małyszko J; Małyszko JS; Hryszko T; Myśliwiec M
    Am J Nephrol; 2001; 21(5):373-7. PubMed ID: 11684797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin and markers of endothelial function in patients undergoing continuous ambulatory peritoneal dialysis.
    Malyszko J; Malyszko JS; Hryszko T; Brzosko S; Mysliwiec M
    Int J Tissue React; 2002; 24(3):111-5. PubMed ID: 12635864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
    Małyszko J; Małyszko JS; Myśliwiec M
    Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis.
    Malyszko J; Malyszko JS; Mysliwiec M
    Perit Dial Int; 2001; 21(2):158-65. PubMed ID: 11330560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased soluble CD40L levels are reduced by long-term simvastatin treatment in peritoneally dialyzed patients.
    Malyszko J; Malyszko JS; Hryszko T; Mysliwiec M
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):463-7. PubMed ID: 15311154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some aspects of hemostasis in CAPD patients treated with erythropoietin.
    Małyszko J; Suchowierska E; Małyszko JS; Myśliwiec M
    Kidney Blood Press Res; 2002; 25(4):240-4. PubMed ID: 12424426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin correlates with some hemostatic parameters in CAPD patients.
    Małyszko J; Wołczyński S; Małyszko J; Myśliwiec M
    Nephron; 2002; 92(3):721-4. PubMed ID: 12372966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the pro-thrombotic state in CAPD patients.
    Preloznik Zupan I; Sabovic M; Salobir B; Buturovic Ponikvar J
    Ren Fail; 2008; 30(6):597-602. PubMed ID: 18661409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients.
    Malyszko J; Malyszko JS; Brzosko S; Wolczynski S; Mysliwiec M
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4620-7. PubMed ID: 15356072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients.
    Suzuki H; Inoue T; Watanabe Y; Kikuta T; Sato T; Tsuda M
    Adv Perit Dial; 2010; 26():53-7. PubMed ID: 21348380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D; Morgan C; Rigby RJ; Westhuyzen J
    Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?
    Małyszko J; Małyszko JS; Myśliwiec M
    Thromb Res; 2005; 115(1-2):19-24. PubMed ID: 15567448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of simvastatin on dyslipemia in continuous ambulatory peritoneal dialysis patients.
    Dimitriadis A; Antoniou S; Hatzisavvas N; Pastore F; Kaldi I; Stangou M
    Perit Dial Int; 1993; 13 Suppl 2():S434-6. PubMed ID: 8399633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects on simvastatin in continuous ambulatory peritoneal dialysis patients with hyperlipidemia].
    Zhu XP; Li J; Liu FY; Liu YH
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):154-6. PubMed ID: 12212206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering therapy and coagulation/fibrinolysis parameters in patients on peritoneal dialysis.
    Yorioka N; Masaki T; Ito T; Kushihata S; Nishida Y; Taniguchi Y; Oda H; Yamakido M
    Int J Artif Organs; 2000 Jan; 23(1):27-32. PubMed ID: 12118834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of simvastatin on hyperlipidemia in CAPD patients.
    Di Paolo B; Del Rosso G; Catucci G; Vocino V; Terenzio MG; Bonomini M; Suriani K; Albertazzi A
    ASAIO Trans; 1990; 36(3):M578-80. PubMed ID: 2252755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.